RNA Avidity Biosciences, Inc. - Common Stock
$12,90
Precio · Ago 18, 2026
Fundamentales a fecha de Feb 23, 2026
Rango 52S
$11–$73
3% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
$25
+94% upside
P/E (TTM)
-2.6
ROE
-47.5%
Margen de Beneficio Neto
-3650.4%
RNA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$12.90
Capitalización Bursátil
$1.95B
P/E (TTM)
-2.6
BPA (TTM)
$-4.97
Ingresos (TTM)
$19M
Rendimiento div.
—
ROE
-47.5%
Deuda/Capital
—
Rango 52S
$11 – $73
RNA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$19M
2018-12-31
→
2025-12-31
BPA
$-4.97
2020-12-31
→
2025-12-31
Flujo de caja libre
$-664M
2020-12-31
→
2025-12-31
Márgenes
-3650.4%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
RNA
Mediana de Pares
P/E (TTM)
-2.6
—
P/S (TTM) (P/V (TTM))
104.0
9.5
P/B (P/C)
1.2
1.1
Price / FCF (Precio / FCF)
-2.9
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
RNA
Mediana de Pares
Operating Margin (Margen Operativo)
-3977.3%
—
Net Profit Margin (Margen de Beneficio Neto)
-3650.4%
-348.2%
ROA
-38.9%
-40.7%
ROE
-47.5%
-49.8%
ROIC
-44.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
RNA
Mediana de Pares
Current Ratio (Ratio corriente)
9.2
12.1
Quick Ratio (Ratio Rápido)
2.0
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
RNA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
72.1%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
26.7%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
22.5%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
RNA
Mediana de Pares
RNA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
4 analistas · 2026-08-19
Mín
$25.00
Máx
$25.00
Objetivo mediano
$25.00
+93,8%
Objetivo medio
$25.00
+93,8%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.09%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.97 | $-1.06 | 0.09% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $11M | $10M | $9M | $9M | $7M | $2M | |
| R&D Expense | $559M | $304M | $191M | $150M | $101M | $38M | $15M | |
| SG&A Expense | $206M | $86M | $54M | $38M | $26M | $13M | $5M | |
| Operating Expenses | $765M | $390M | $245M | $188M | $127M | $51M | $20M | |
| Operating Income | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | $-17M | |
| Interest Expense | · | · | · | $0 | $0 | $209.0K | $7M | |
| Other Non-op | $-2M | $-248.0K | $-594.0K | $-57.0K | $-62.0K | $-75.0K | $0 | |
| Pretax Income | $-685M | $-322M | $-212M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | $-25M | |
| EPS (Basic) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| EPS (Diluted) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| Shares (Basic) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| Shares (Diluted) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| EBITDA | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | · |
Balance general 24
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $220M | $185M | $340M | $320M | $321M | $95M | |
| Short-term Investments | · | · | · | · | $85M | $7M | · | |
| Receivables | · | $0 | $1M | $2M | · | · | · | |
| Prepaid Expense | $102M | $41M | $16M | $12M | $6M | · | · | |
| Other Current Assets | $53M | $19M | · | $2M | · | · | · | |
| Current Assets | $1.80B | $1.54B | $611M | $623M | $411M | $332M | $96M | |
| PP&E (Net) | $23M | $13M | $8M | $6M | $5M | $1M | $631.0K | |
| PP&E (Gross) | $35M | $21M | $14M | $9M | $7M | $3M | $2M | |
| Accum. Depreciation | $12M | $8M | $5M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $521.0K | $301.0K | $598.0K | $599.0K | $47.0K | $600.0K | |
| Total Assets | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Accounts Payable | $12M | $8M | $9M | $5M | $3M | $8M | $2M | |
| Current Liabilities | $195M | $98M | $81M | $52M | $30M | $15M | $10M | |
| Capital Leases | $45M | $3M | $6M | $8M | $10M | $938.0K | $393.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $45.0K | |
| Total Liabilities | $269M | $139M | $128M | $61M | $46M | $28M | $28M | |
| Long-term Debt | · | · | · | · | · | · | $5M | |
| Common Stock | $15.0K | $12.0K | $8.0K | $7.0K | $5.0K | $4.0K | $0 | |
| Paid-in Capital | · | · | · | $939M | $566M | $373M | $-43M | |
| Retained Earnings | $-1.58B | $-893M | $-571M | $-359M | $-185M | $-67M | $-22M | |
| AOCI | $3M | $3M | $125.0K | $-3M | $-187.0K | $-5.0K | · | |
| Stockholders' Equity | $1.69B | $1.42B | $501M | $578M | $381M | $306M | $-65M | |
| Liabilities + Equity | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Shares Outstanding | 151,205,000 | 119,893,000 | 79,275,000 | 69,768,000 | 47,754,000 | 37,569,000 | 2,989,000 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $98M | $51M | $38M | $27M | $17M | $4M | $406.0K | |
| Operating Cash Flow | $-650M | $-301M | $-119M | $-136M | $-95M | $-37M | $2M | |
| CapEx | $13M | $7M | $4M | $3M | $4M | $1M | $235.0K | |
| Investing Cash Flow | $-38M | $-854M | $-130M | $-190M | $-83M | $-8M | $-235.0K | |
| Net Debt Issued | · | · | · | $0 | $0 | $-5M | · | |
| Stock Issued | $837M | $762M | $61M | $345M | $175M | $274M | · | |
| Net Stock Activity | $837M | $762M | $61M | $345M | $20M | · | · | |
| Financing Cash Flow | $851M | $1.19B | $94M | $346M | $176M | $272M | $89M | |
| Net Change in Cash | $163M | $37M | $-155M | $20M | $-1M | $227M | $91M | |
| Free Cash Flow | $-664M | $-308M | $-123M | $-139M | $-99M | $-38M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| Net Margin | -3650.4% | -2957.7% | -2219.9% | -1886.3% | -1265.4% | -653.5% | · | |
| Pretax Margin | -3650.4% | · | · | · | · | · | · | |
| EBITDA Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| ROA | -38.9% | -29.4% | -33.5% | -32.6% | -31.0% | -20.6% | · | |
| ROE | -47.5% | -22.0% | -41.7% | -36.4% | -30.4% | -14.2% | · | |
| ROIC | -44.2% | · | · | · | · | · | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 | 22.7 | · | |
| Quick Ratio | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 | 22.5 | · | |
| Interest Coverage | · | · | · | · | · | -211.9 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 19.7 | 5.5 | · | · | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 72.1% | 14.0% | 3.6% | -1.1% | 37.4% | · | · | |
| Revenue CAGR 3Y | 26.7% | 5.3% | 12.1% | · | · | · | · | |
| Revenue CAGR 5Y | 22.5% | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $11M | $10M | $9M | $9M | $7M | · | |
| Net Income TTM | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | · | |
| Market Cap | $10.91B | $3.49B | $717M | $1.55B | $1.14B | $959M | · | |
| P/E | -14.5 | -10.1 | -3.1 | -6.6 | -8.3 | -12.4 | · | |
| P/S | 581.5 | 319.9 | 75.0 | 167.8 | 121.7 | 141.3 | · | |
| P/B | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Tangible Book | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Cash Flow | -16.8 | -11.6 | -6.0 | -11.4 | -12.0 | -25.8 | · | |
| P / FCF | -16.4 | -11.3 | -5.8 | -11.1 | -11.5 | -25.1 | · | |
| Earnings Yield | -6.9% | -9.9% | -32.1% | -15.0% | -12.0% | -8.0% | · |
Estado de resultados 12
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $860.0K | $12M | $4M | $2M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $167M | $155M | $138M | $99M | $96M | $77M | $64M | $67M | $53M | $48M | $43M | $48M | $46M | $37M | $40M | $28M | |
| SG&A Expense | $89M | $46M | $37M | $34M | $28M | $23M | $21M | $14M | $16M | $14M | $12M | $12M | $10M | $10M | $9M | $9M | |
| Operating Expenses | $255M | $201M | $175M | $133M | $124M | $100M | $85M | $81M | $69M | $61M | $55M | $60M | $56M | $47M | $48M | $36M | |
| Operating Income | $-254M | $-189M | $-171M | $-132M | $-121M | $-98M | $-83M | $-77M | $-67M | $-59M | $-53M | $-58M | $-53M | $-45M | $-46M | $-34M | |
| Other Non-op | $-477.0K | $-380.0K | $-651.0K | $-435.0K | $201.0K | $-232.0K | $-116.0K | $-101.0K | $-105.0K | $-13.0K | $-162.0K | $-314.0K | $-18.0K | $-12.0K | $-2.0K | $-25.0K | |
| Net Income | $-237M | $-174M | $-157M | $-116M | $-102M | $-80M | $-71M | $-69M | $-60M | $-52M | $-47M | $-52M | $-50M | $-44M | $-46M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| EPS (Diluted) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| Shares (Basic) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| Shares (Diluted) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| EBITDA | · | $-189M | $-171M | $-132M | · | $-98M | $-83M | $-77M | · | $-59M | $-53M | $-58M | · | $-45M | · | $-34M |
Balance general 21
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $350M | $244M | $254M | $220M | $370M | $576M | $471M | · | $86M | $154M | $119M | · | $144M | $125M | $139M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $262M | $273M | $258M | |
| Receivables | · | · | · | · | · | $0 | $0 | $2M | · | · | $1M | · | · | · | · | · | |
| Prepaid Expense | $102M | $90M | $67M | $55M | $41M | $33M | $30M | $19M | · | · | $11M | · | · | · | · | · | |
| Other Current Assets | $53M | $60M | $43M | · | $19M | · | · | · | · | · | $6M | · | · | · | · | · | |
| Current Assets | $1.80B | $1.97B | $1.25B | $1.43B | $1.54B | $1.62B | $1.33B | $934M | · | $555M | $595M | $597M | · | $414M | $404M | $405M | |
| PP&E (Net) | $23M | $22M | $21M | $16M | $13M | $9M | $8M | $9M | · | $8M | $8M | $8M | · | $6M | $6M | $5M | |
| PP&E (Gross) | $35M | $32M | $30M | $24M | $21M | $17M | $15M | $15M | · | $13M | $12M | $11M | · | $9M | $9M | $7M | |
| Accum. Depreciation | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | $2M | $2M | |
| Other Non-current Assets | $82M | $91M | $91M | $739.0K | $521.0K | $318.0K | $364.0K | $425.0K | · | $344.0K | $424.0K | $474.0K | · | $523.0K | $415.0K | $548.0K | |
| Total Assets | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Accounts Payable | $12M | $10M | $4M | $7M | $8M | $8M | $9M | $2M | · | $6M | $6M | $4M | · | $26M | $21M | $19M | |
| Current Liabilities | $195M | $170M | $135M | $85M | $98M | $91M | $84M | $75M | · | $49M | $45M | $48M | · | $43M | $34M | $31M | |
| Capital Leases | $45M | $46M | $1M | $2M | $3M | $4M | $5M | $5M | · | $7M | $6M | $7M | · | $8M | $9M | $9M | |
| Total Liabilities | $269M | $248M | $176M | $130M | $139M | $137M | $126M | $121M | · | $56M | $52M | $55M | · | $54M | $46M | $45M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $10.0K | · | $7.0K | $7.0K | $7.0K | · | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.58B | $-1.34B | $-1.17B | $-1.01B | $-893M | $-791M | $-710M | $-640M | · | $-510M | $-458M | $-411M | · | $-308M | $-264M | $-219M | |
| AOCI | $3M | $2M | $2M | $3M | $3M | $7M | $-453.0K | $-464.0K | · | $-2M | $-3M | $-2M | · | $-3M | $-3M | $-2M | |
| Stockholders' Equity | $1.69B | $1.89B | $1.19B | $1.33B | $1.42B | $1.50B | $1.22B | $831M | $501M | $517M | $559M | $559M | $578M | $377M | $374M | $376M | |
| Liabilities + Equity | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Shares Outstanding | 151,205,000 | 146,771,000 | 120,778,000 | 120,512,000 | 119,893,000 | 118,900,000 | 109,266,000 | 95,594,000 | 79,275,000 | 74,101,000 | 74,070,000 | 70,813,000 | 69,768,000 | 54,446,000 | 52,081,000 | 49,281,000 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43M | $19M | $18M | $18M | $14M | $14M | $13M | $10M | $10M | $10M | $9M | $9M | $7M | $7M | $7M | $6M | |
| Operating Cash Flow | $-170M | $-156M | $-200M | $-125M | $-100M | $-66M | $-65M | $-70M | $17M | $-37M | $-50M | $-49M | $-39M | $-32M | $-36M | $-30M | |
| CapEx | $6M | $712.0K | $3M | $4M | $4M | $2M | $531.0K | $915.0K | $863.0K | $923.0K | $622.0K | $2M | $850.0K | $-107.0K | $1M | $758.0K | |
| Investing Cash Flow | $207M | $-588M | $185M | $157M | $-64M | $-482M | $-275M | $-33M | $51M | $-31M | $46M | $-196M | $-8M | $11M | $-18M | $-175M | |
| Stock Issued | $-538.0K | $837M | $0 | $0 | $-500.0K | $324M | $433M | $6M | $0 | $0 | $38M | $22M | $243M | $39M | $38M | $24M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $6M | · | · | · | $22M | · | · | · | $24M | |
| Financing Cash Flow | $-5M | $850M | $4M | $2M | $14M | $342M | $447M | $389M | $32M | $40.0K | $39M | $23M | $244M | $40M | $39M | $24M | |
| Net Change in Cash | $32M | $106M | $-10M | $34M | $-150M | $-206M | $107M | $286M | $99M | $-68M | $35M | $-222M | $197M | $19M | $-14M | $-181M | |
| Free Cash Flow | · | · | · | $-129M | · | · | · | $-71M | · | · | · | $-51M | · | · | · | $-30M |
Rentabilidad 5
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| Net Margin | · | -1398.3% | -4089.3% | -7360.0% | · | -3441.7% | -3461.8% | -1943.4% | · | -1858.0% | -2030.4% | -2346.3% | · | -1756.6% | · | -1907.2% | |
| EBITDA Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| ROA | · | -9.2% | -11.6% | -9.6% | · | -7.3% | -7.2% | -8.8% | · | -10.4% | -9.1% | -10.1% | · | -10.2% | · | -9.3% | |
| ROE | · | -10.3% | -13.0% | -10.7% | · | -8.0% | -8.0% | -9.9% | · | -11.7% | -10.1% | -11.2% | · | -11.3% | · | -10.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.6 | 9.3 | 16.9 | · | 17.8 | 15.8 | 12.5 | · | 11.4 | 13.1 | 12.4 | · | 9.7 | · | 13.1 | |
| Quick Ratio | · | 2.1 | 1.8 | 3.0 | · | 4.1 | 6.8 | 6.3 | · | 1.8 | 3.4 | 2.5 | · | 9.5 | · | 12.8 |
Eficiencia 2
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 3.5 | 4.5 | · | · | 3.9 | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $20M | $10M | $9M | · | $11M | $11M | $11M | · | $10M | $9M | $9M | · | $9M | · | $9M | |
| Net Income TTM | · | $-528M | $-424M | $-336M | · | $-272M | $-239M | $-221M | · | $-195M | $-189M | $-176M | · | $-153M | · | $-114M | |
| Market Cap | · | $6.39B | $3.43B | $3.56B | · | $5.46B | $4.46B | $2.44B | · | $473M | $821M | $1.09B | · | $889M | · | $910M | |
| P/E | · | -10.8 | -8.3 | -9.9 | · | -16.4 | -14.5 | -8.8 | · | -2.2 | -3.5 | -4.8 | · | -5.2 | · | · | |
| P/S | · | 316.1 | 350.0 | 374.6 | · | 508.4 | 416.3 | 223.6 | · | 48.0 | 89.2 | 125.1 | · | 103.2 | · | 98.2 | |
| P/B | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Tangible Book | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Cash Flow | · | · | · | -28.5 | · | · | · | -34.7 | · | · | · | -22.2 | · | · | · | -30.8 | |
| P / FCF | · | · | · | -27.7 | · | · | · | -34.2 | · | · | · | -21.4 | · | · | · | -30.0 | |
| Earnings Yield | · | -9.2% | -12.0% | -10.1% | · | -6.1% | -6.9% | -11.4% | · | -45.9% | -28.3% | -20.8% | · | -19.2% | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $19M | $11M | $10M | $9M | $9M |
| Margen Operativo % | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% |
| Beneficio neto | $-685M | $-322M | $-212M | $-174M | $-118M |
| EPS Diluido | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 |
| Ratio Rápido | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-664M | $-308M | $-123M | $-139M | $-99M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 20 declarantes · $102.7M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 0 (0 vs trimestre anterior) | 1 (-322 vs trimestre anterior) | 0 (0 vs trimestre anterior) | 1 (0 vs trimestre anterior) | -8K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| KRYGER CAPITAL Ltd | $75 398 932 | 1 045 320 | 73,42% | Acciones |
| VANGUARD GROUP INC | $6 863 530 | 95 155 | 6,68% | Acciones |
| EFG Asset Management (North America) Corp. | $6 499 913 | 149 149 | 6,33% | Acciones |
| AXA Investment Managers S.A. | $4 429 239 | 101 658 | 4,31% | Acciones |
| ANGELO GORDON & CO., L.P. | $3 245 850 | 45 000 | 3,16% | Acciones |
| Toroso Investments, LLC | $2 628 417 | 36 440 | 2,56% | Acciones |
| WOLVERINE TRADING, LLC | $1 023 120 | 24 000 | 1,00% | Opción de compra |
| Orion Portfolio Solutions, LLC | $675 595 | 22 886 | 0,66% | Acciones |
| CIBC WORLD MARKETS CORP | $552 372 | 7 658 | 0,54% | Acciones |
| WOLVERINE TRADING, LLC | $456 141 | 10 700 | 0,44% | Opción de venta |
| Eisler Capital Management Ltd. | $322 088 | 7 600 | 0,31% | Opción de compra |
| WOLVERINE TRADING, LLC | $285 493 | 6 697 | 0,28% | Acciones |
| Nuveen Asset Management, LLC | $167 268 | 5 752 | 0,16% | Acciones |
| AlphaQuest LLC | $104 589 | 1 450 | 0,10% | Acciones |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $19 572 | 663 | 0,02% | Acciones |
| Lindbrook Capital, LLC | $16 708 | 566 | 0,02% | Acciones |
| COMERICA BANK | $10 956 | 152 | 0,01% | Acciones |
| Byrne Asset Management LLC | $1 372 | 102 | 0,00% | Acciones |
| FTB Advisors, Inc. | $511 | 18 | 0,00% | Acciones |
| Hemington Wealth Management | $0 | 7 | 0,00% | Acciones |
Informantes de la empresa 20 insiders · 11 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Sarah Boyce | President and CEO | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Michael F Maclean | Chief Financial Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Joseph Baroldi | Chief Operating Officer | 2 de febrero de 2021 A | — | 0 | 0 | $0 |
| Charles Calderaro III | Chief Technical Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Kathleen P. Gallagher | Chief Program Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Teresa Mccarthy | Chief Human Resources Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Michael W. Flanagan | Chief Scientific Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Eric Mosbrooker | Chief Commercial Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| John B Moriarty | Chief Legal Officer | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Jae B. Kim | Chief Medical Officer | 2 de febrero de 2021 A | — | 0 | 0 | $0 |
| Simona Skerjanec | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Jean Jinsun Kim | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Tamar Thompson | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Noreen Henig | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Troy Edward Wilson | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Edward M. Kaye MD | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Carsten Boess | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Consejero | 27 de febrero de 2026 D | 0 | 0 | 0 | $0 |
| Roderick Wong, M.D. | — | 16 de junio de 2021 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RTW Investments, LP, Roderick Wong ×6 presentaciones | 29 de octubre de 2025 | 3,10% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 15 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 48 184 SH | 8 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 4 415 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 82 327 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 10 724 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 85 960 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 369 738 SH | 8 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,00% | 40 687 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 2 952 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 3 267 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 188 626 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 518 416 SH | 8 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 8 760 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 882 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 933 SH | 8 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,00% | 3 329 SH | 8 de agosto de 2026 | Diario |